Enter Sofosbuvir: The Path to Curing HCV Michael J. Sofia Cell Volume 167, Issue 1, Pages 25-29 (September 2016) DOI: 10.1016/j.cell.2016.08.044 Copyright © 2016 Terms and Conditions
Discovery research leadership team at Pharmasset (L to R: Michael Sofia, Michael Otto, and Phil Furman). Cell 2016 167, 25-29DOI: (10.1016/j.cell.2016.08.044) Copyright © 2016 Terms and Conditions
The chemistry team at Pharmasset: January 2012. Cell 2016 167, 25-29DOI: (10.1016/j.cell.2016.08.044) Copyright © 2016 Terms and Conditions
Dr. Onaiwu Ogbomo (L), cured by sofosbuvir-based regimen, and Michael Sofia (R) at the FDA Advisory Board Meeting on October 25, 2013. Cell 2016 167, 25-29DOI: (10.1016/j.cell.2016.08.044) Copyright © 2016 Terms and Conditions